PsychiatricTimes Members: Login | Register
PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Substance-Related Disorders

Psychiatric Times. Vol. 28 No. 6
Pages: 1  2  3  4  
Previous
SUBSTANCE ABUSE: ADDICTION & RECOVERY 

Novel Therapies for Cognitive Dysfunction Secondary to Substance Abuse

Brief Screening, Referral, and Cognitive Rehabilitation

By Antonio Verdejo-García, PhD | June 8, 2011
Dr Verdejo-García is Researcher and Lecturer at the Department of Clinical Psychology and Institute of Neuroscience, Universidad de Granada, Spain. He reports no conflicts of interest concerning the subject matter of this article.

In cocaine use disorders, deficits in working memory, disinhibition, decision making, and emotional processing persist at mid-term recovery; at long-term recovery, there are persistent deficits in flexibility and decision making. Methamphetamine is one of the more cognitively pervasive drugs, since deficits in episodic and working memory, disinhibition, and emotional processing persist at long-term recovery.

In the case of heavy MDMA (3,4-methylenedioxymethamphetamine) use, deficits in episodic and working memory, selective attention, and disinhibition may persist at mid-term recovery, whereas only mild deficits in episodic and working memory are manifest at long-term recovery. In heroin addiction, deficits in memory, attention, initiation of controlled response, disinhibition, and emotional process-ing persist at mid-term abstinence, and at long-term abstinence, working memory and decision-making skills are still significantly altered. Finally, with alcohol(Drug information on alcohol) dependence, there are deficits in memory, selective attention, and emotional processing at mid-term abstinence and persistent deficits in visual-spatial skills and decision making at long-term abstinence.

(MORE: Comorbid Depression and Alcohol Dependence)

Research on rehabilitation of cognitive deficits in addiction is in its infancy, but it seems clear that deficits in working memory, disinhibition, decision making, and emotional processing are by far the most significant and the most pervasive, so those should be our targets. As in other applications of neuropsychological rehabilitation, there are 2 complementary routes we can follow: attempt to restore these processes through intense stimulation, and attempt to compensate these deficits to optimize performance during activities of daily living.

The results of a recent study that applied cognitive stimulation of working memory functions in psychostimulant-dependent patients showed significant reductions of disinhibition (defined as decreased preference for small immediate rewards over more delayed ones) after 1 month of training.23 We used a holistic approach that combines Goal Management Training (GMT) for rehabilitation of executive functions with mindfulness meditation for training of emotional feedback relevant to focused attention and decision making.24 Our results showed significant improvements in working memory, disinhibition, and decision making after 7 weeks of treatment for mixed alcohol and cocaine polysubstance dependence.25

GMT relies on cognitive stimulation and promotion of treatment-relevant activities of daily living; therefore, it may constitute a more thorough and easy way to generalize intervention. Both studies support the feasibility of applying cognitive rehabilitation in patients with substance dependence. Another option is to adjust usual cognitive-behavioral interventions to the individual profile of cognitive dysfunction of each patient. For example, these interventions may consist of feedback-based learning rather than complex instructions in patients with attention/working memory problems or of compensation of disinhibition problems with community reinforcement approach strategies based on the achievement of delayed rewards. Clearly, future research is needed to support the long-term effectiveness of these interventions on clinical outcome variables (eg, craving, relapse); in the meantime, we have reasons to support the usefulness of a neuropsychological approach to problems of substance dependence.

Pages: 1  2  3  4  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Richard Ash | June 16, 2011 8:24 PM EDT

I am a pancreatic cancer survivor ( 7 years ) but will have lifetime pain as the tumor was lying against the celiac sheath on the perineural nerve and had to be scraped. I take 1200 MG daily of MS-Contin ER in addition to 100MCH Fentanyl patches every three days and, 10/325 Hydrocodone for breakthough pain. I am managed by the Pain Clinic at Vanderbilt in Nashville.

I hold down a full time job of excruciating attention to detail. Creating Excel, Word and Powerpoint quotations, proposals and Statements of Work for Account Executives. ( I was an Outside Sales Rep for 25 years in Hi-Tech selling to Fortune 100 companies )

Your article on the effect of opiods on attention and other executive deficits is of interest to me as I now have to be a bit more careful in reviewing my work before submission. There is a small increment of ADD as I will spontaneously stop working to check personal emails, browse the internet on articles related to our core expertise or take a break and turn upthe volume on the wall TV in the office. I work alone, in an office outsie the home but on my property.

But, these are conscious decisions. I don't suddenly find myself away from the task at hand, rather it is a break from the tedium and, I do ( as stated ) have to be cautious about grammar and diarrhea of the keyboard.

If anyone is interested in asking me questions about my experiece you may reach me at rickash@windstream.net

Interesting work, Thank You for the posting.

Also in this Special Report

Introduction: Comorbidity, Cognition, and Pharmacotherapies

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence

Novel Therapies for Cognitive Dysfunction Secondary to Substance Abuse

Comorbid Depression and Alcohol Dependence





References

1. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403-1413.

2. Koob GF, Volkow ND. Neurocircuitry of addiction [published correction appears in Neuropsychopharmacology. 2010;35:1051]. Neuropsychopharmacology. 2010;35:217-238.

3. Fernández-Serrano MJ, Pérez-García M, Verdejo-García A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev. 2011;35:377-406.

4. Fernández-Serrano MJ, Pérez-García M, Schmidt Río-Valle J, Verdejo-García A. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J Psychopharmacol. 2010;24:1317-1332.

5. Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32:777-810.

6. Feil J, Sheppard D, Fitzgerald PB, et al. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev. 2010;35:248-275.

7. Belin D, Mar AC, Dalley JW, et al. High impulsivity predicts the switch to compulsive cocaine-taking. Science. 2008;320:1352-1355.

8. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci. 2005;8:1450-1457.

9. Cherner M, Bousman C, Everall I, et al; HNRC Group. Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc. 2010;16:890-901.

10. Verdejo-García A, Pérez-García M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl). 2007;190:517-530.

11. Stuss DT, Alexander MP. Executive functions and the frontal lobes: a conceptual view. Psychol Res. 2000;63:289-298.

12. Robbins TW. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci. 2007;362:917-932.

13. Ferníndez-Serrano MJ, Pérez-García M, Perales JC, Verdejo-García A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur J Pharmacol. 2010;626:104-112.

14. Streeter CC, Terhune DB, Whitfield TH, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008;33:827-836.

15. Turner TH, LaRowe S, Horner MD, et al. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009;37:328-334.

16. Passetti F, Clark L, Mehta MA, et al. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008;94:82-91.

17. Grace J, Malloy PF. Frontal Systems Behavior Scale (FrSBe): Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc; 2001.

18. Verdejo-García A, Bechara A, Recknor EC, Pérez-García M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc. 2006;12:405-415.

19. Frontal Systems Behavioral Scale (FrSBe). http://www.parinc.com. Accessed April 29, 2011.

20. Golden CJ. Stroop Color and Word Test Manual. Los Angeles: Western Psychological Services; 1978.

21. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin Card Sorting Test-64 Card Version: Professional Manual. Odessa, FL: Psychological Assessment Resources; 2000.

22. Bechara A. Iowa Gambling Task Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc; 2001.

23. Bickel WK, Yi R, Landes RD, et al. Remember the future: working memory training decreases delay discounting among stimulant addicts. Biol Psychiatry. 2011;69:260-265.

24. Robertson IH, Levine B, Manly T. Goal Management Training. Toronto: Baycrest Rotman Research Institute; 2005.

25. Alfonso JP, Caracuel A, Delgado-Pastor LC, Verdejo-García A. Combined goal management training and mindfulness meditation improve executive functions and decision-making performance in abstinent polysubstance abusers. Drug Alcohol Depend. 2011 Jan 28; [Epub ahead of print].


 
RELATED TOPICS
Munchasuen syndrome
Substance Abuse
Opioid-related disorders
Neonatal abstinence syndrome
Cocaine-related disorders
Morphine dependence
Substance-related disorders
Substance abuse detection
Intravenous substance abuse
Eating disorders
Gambling
Trichotillomania
Physiological Sexual Dysfunction
Sexual Child Abuse
Sexual Harassment
Psychological Sexual Dysfunctions
Sexual And Gender Disorders
Social Behavior
Sex differentiation disorders
Sadism
Masochism
Internet Addiction

 


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
CME
Breaking the Cycle of Substance Abuse and Addiction: Focus on Management Strategies
Approaching Crossroads in Psychiatry: Eating Disorders, Suicide and Substance Abuse
More Addiction CME


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Substance Related Disorders
Evidence on Substance Related Disorders
Guidelines on Substance Related Disorders
Patient Education on Substance Related Disorders
Clinical Trials on Substance Related Disorders
Practical Articles on Substance Related Disorders
Research and Reviews on Substance Related Disorders
All "Substance Related Disorders" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy